Publications

The following is a list of some of the many medical journals and articles authored by or featuring our team here at Peninsula Research Associates.

• Prevalence of Comorbidities with Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) The Journal of Allergy and Clinical Immunology February 2019.
• A Randomized Phase 3 Study, Sinus-52, Evaluating the Efficacy and Safety of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps The Journal of Allergy and Clinical Immunology, February 2019. 
• AR101 Oral Immunotherapy for Peanut Allergy The New England Journal of Medicine, 22 November 2018. 
• Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma The New England Journal of Medicine 28 June 2018.
• Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma The New England Journal of Medicine, 28 June 2018. 
• Treatment of Asthmatic Patients with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Compared with Placebo: Patient-Reported Outcomes and Quality of Life The Journal of Allergy and Clinical Immunology, February 2017.
• Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis The Journal of Allergy and Clinical Immunology, February 2017.
• Dupilumab in Persistent Asthma with Elevated Eosinophil Levels The New England Journal of Medicine, 27 June 2013.
• Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma The Journal of Allergy and Clinical Immunology, February 2014.
• Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.

Updated June 24, 2021